Multiple Manufacturers

ABRAXANE

Manufacturer:

Multiple Manufacturers

Abraxane HCPCS:

J9264

HCPCS Code Descriptor:

Injection, paclitaxel protein-bound particles, 1 mg

Category:

J Code

Abraxane NDCs:

24979-0710-51, 68817-0134-50, 60505-6230-04

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Abraxane:

ABRAXANE is a medication manufactured by multiple manufacturers and aligned to the J Code: J9264. ABRAXANE is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J9264 Added Date:

January 1, 2006

J9264 Effective Date:

January 1, 2007

J9264 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Abraxane billing and coding information.
Abraxane patient assistance information can be found through Bristol Myers Squibb Access Support at the URL: https://www.bmsaccesssupport.bmscustomerconnect.com/patient
ABRAXANE prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for ABRAXANE. Please check back in a few weeks.